James Manuso - Jan 2, 2025 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role: Director
Signature: /s/ Amy Rabourn, by Power of Attorney
Stock symbol: IRD
Transactions as of: Jan 2, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/6/2025, 04:43 PM
Previous filing: Oct 22, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRD	Common Stock	Award		+50.2K	+38.04%		182K	Jan 2, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted shares of common stock in lieu of cash for board services for 2025. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock on the grant date (rounded down to the nearest whole share). The average fair market value was $1.23 per share, the average of the high and low price of the common stock on the date of grant.

Content

The Reporting Person was granted shares of common stock in lieu of cash for board services for 2025. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock on the grant date (rounded down to the nearest whole share). The average fair market value was $1.23 per share, the average of the high and low price of the common stock on the date of grant.